Suzanne C. Cannegieter

21.5k total citations · 7 hit papers
333 papers, 14.3k citations indexed

About

Suzanne C. Cannegieter is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Suzanne C. Cannegieter has authored 333 papers receiving a total of 14.3k indexed citations (citations by other indexed papers that have themselves been cited), including 217 papers in Internal Medicine, 135 papers in Cardiology and Cardiovascular Medicine and 96 papers in Hematology. Recurrent topics in Suzanne C. Cannegieter's work include Venous Thromboembolism Diagnosis and Management (217 papers), Blood Coagulation and Thrombosis Mechanisms (91 papers) and Atrial Fibrillation Management and Outcomes (84 papers). Suzanne C. Cannegieter is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (217 papers), Blood Coagulation and Thrombosis Mechanisms (91 papers) and Atrial Fibrillation Management and Outcomes (84 papers). Suzanne C. Cannegieter collaborates with scholars based in Netherlands, Norway and Denmark. Suzanne C. Cannegieter's co-authors include Frits R. Rosendaal, E Briët, F.R. Rosendaal, F.J.M. van der Meer, Willem M. Lijfering, Sverre Christian Christiansen, Sigrid K. Brækkan, J.F. Timp, Inger Anne Næss and Jan P. Vandenbroucke and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Suzanne C. Cannegieter

310 papers receiving 13.9k citations

Hit Papers

A Method to Determine the Optimal Intensity of Oral Antic... 1993 2026 2004 2015 1993 2007 2013 1994 1995 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
    1993 1.6k citations Suzanne C. Cannegieter, F.J.M. van der Meer et al. profile →
  2. Incidence and mortality of venous thrombosis: a population‐based study
    2007 1.0k citations Inger Anne Næss, Suzanne C. Cannegieter et al. Journal of Thrombosis and Haemostasis profile →
  3. Epidemiology of cancer-associated venous thrombosis
    2013 822 citations J.F. Timp, Sigrid K. Brækkan et al. profile →
  4. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.
    1994 747 citations Suzanne C. Cannegieter et al. profile →
  5. Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves
    1995 674 citations Suzanne C. Cannegieter, F.J.M. van der Meer et al. profile →
  6. Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH
    2016 401 citations Suzanne C. Cannegieter, Paul A. Kyrle et al. Journal of Thrombosis and Haemostasis profile →
  7. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature
    2017 306 citations Yvonne M. Ende-Verhaar, Suzanne C. Cannegieter et al. European Respiratory Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne C. Cannegieter Netherlands 55 7.4k 7.1k 2.9k 2.7k 1.6k 333 14.3k
Peter Verhamme Belgium 53 5.5k 0.7× 7.1k 1.0× 2.3k 0.8× 1.7k 0.6× 1.8k 1.1× 350 13.1k
James D. Douketis Canada 56 7.9k 1.1× 8.1k 1.1× 3.4k 1.2× 1.6k 0.6× 915 0.6× 238 13.2k
Saskia Middeldorp Netherlands 62 8.0k 1.1× 5.7k 0.8× 2.9k 1.0× 5.8k 2.1× 1.2k 0.7× 369 16.5k
Kenneth A. Bauer United States 60 7.6k 1.0× 6.4k 0.9× 3.0k 1.0× 5.4k 2.0× 878 0.5× 201 13.6k
Walter Ageno Italy 67 13.7k 1.8× 11.4k 1.6× 4.0k 1.4× 3.6k 1.3× 2.8k 1.7× 557 20.5k
Peter K. Henke United States 63 4.8k 0.6× 3.7k 0.5× 5.3k 1.8× 2.2k 0.8× 1.1k 0.7× 367 13.3k
Francesco Dentali Italy 37 7.9k 1.1× 7.1k 1.0× 3.6k 1.2× 1.8k 0.7× 1.4k 0.8× 194 13.4k
Marc Rodger Canada 62 9.9k 1.3× 6.6k 0.9× 3.3k 1.1× 3.9k 1.4× 1.2k 0.7× 271 14.6k
Stavros Konstantinides Germany 68 11.4k 1.5× 9.4k 1.3× 2.7k 0.9× 1.6k 0.6× 4.7k 2.9× 452 18.3k
Philip S. Wells Canada 63 14.9k 2.0× 10.4k 1.5× 5.6k 1.9× 3.2k 1.2× 2.0k 1.2× 299 19.7k

Countries citing papers authored by Suzanne C. Cannegieter

Since Specialization
Citations

This map shows the geographic impact of Suzanne C. Cannegieter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne C. Cannegieter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne C. Cannegieter more than expected).

Fields of papers citing papers by Suzanne C. Cannegieter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne C. Cannegieter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne C. Cannegieter. The network helps show where Suzanne C. Cannegieter may publish in the future.

Co-authorship network of co-authors of Suzanne C. Cannegieter

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne C. Cannegieter. A scholar is included among the top collaborators of Suzanne C. Cannegieter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne C. Cannegieter. Suzanne C. Cannegieter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cannegieter, Suzanne C., et al.. (2025). Portal vein intimal thickening in patients with cirrhosis is associated with indicators of portal hypertension. Journal of Thrombosis and Haemostasis. 23(5). 1551–1561. 1 indexed citations
2.
Ali, Mariam, Hendrikus J. A. van Os, Suzanne C. Cannegieter, et al.. (2025). Coagulation Factors and White Matter Hyperintensities in Middle‐Aged Women With and Without Migraine and Ischemic Stroke. European Journal of Neurology. 32(3). e70063–e70063.
3.
4.
Søgaard, Mette, Martin Bach Jensen, Eric C. T. Geijteman, et al.. (2024). Use of antithrombotic therapy and the risk of cardiovascular outcomes and bleeding in cancer patients at the end of life: a Danish nationwide cohort study. Journal of Thrombosis and Haemostasis. 23(1). 190–200. 3 indexed citations
5.
6.
Barco, Stefano, Suzanne C. Cannegieter, Marion Delcroix, et al.. (2023). Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: an updated systematic review and meta-analysis. European Respiratory Journal. 62(1). 2300449–2300449. 29 indexed citations
7.
Nemeth, Banne, Raymond A. van Adrichem, Astrid van Hylckama Vlieg, et al.. (2023). Enhanced in vivo and ex vivo thrombin generation after lower-leg trauma, but not after knee arthroscopy. Thrombosis Journal. 21(1). 49–49.
8.
Yap, Eng Soo, Willem M. Lijfering, J.F. Timp, et al.. (2023). Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study. SHILAP Revista de lepidopterología. 4(1). 3–12. 2 indexed citations
9.
Kaptein, Fleur H.J., Milou A.M. Stals, Suzanne C. Cannegieter, et al.. (2022). Incidence and determinants of thrombotic and bleeding complications in patients with glioblastoma. Journal of Thrombosis and Haemostasis. 20(7). 1665–1673. 22 indexed citations
10.
Morelli, Vânia M., Renée de Mutsert, Albert de Roos, et al.. (2020). Association Between Hepatic Triglyceride Content and Coagulation Factors. Arteriosclerosis Thrombosis and Vascular Biology. 40(12). 3004–3014. 8 indexed citations
11.
Nemeth, Banne, et al.. (2019). Validation of risk assessment models for venous thrombosis in hospitalized medical patients. Research and Practice in Thrombosis and Haemostasis. 3(2). 217–225. 14 indexed citations
12.
Douillet, Delphine, Banne Nemeth, Andréa Penaloza, et al.. (2019). Venous thromboembolism risk stratification for patients with lower limb trauma and cast or brace immobilization. PLoS ONE. 14(6). e0217748–e0217748. 13 indexed citations
13.
Kooiman, Judith, Jean‐Paul P.M. de Vries, Jan Van der Heyden, et al.. (2018). Randomized trial of one-hour sodium bicarbonate vs standard periprocedural saline hydration in chronic kidney disease patients undergoing cardiovascular contrast procedures. PLoS ONE. 13(2). e0189372–e0189372. 7 indexed citations
14.
Dronkers, C.E.A., Yvonne M. Ende-Verhaar, Paul A. Kyrle, et al.. (2017). Disease prevalence dependent failure rate in diagnostic management studies on suspected deep vein thrombosis: communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 15(11). 2270–2273. 17 indexed citations
15.
Rein, Nienke van, et al.. (2017). Multi‐dose drug dispensing as a tool to improve medication adherence: A study in patients using vitamin K antagonists. Pharmacoepidemiology and Drug Safety. 27(1). 46–51. 11 indexed citations
16.
Dekkers, Olaf M., Erzsébet Horváth–Puhó, Jens Otto Lunde Jørgensen, et al.. (2013). Multisystem Morbidity and Mortality in Cushing's Syndrome: A Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 98(6). 2277–2284. 290 indexed citations
17.
Grosse, Scott D., Ekwutosi M. Okoroh, Sigrid K. Brækkan, et al.. (2013). Venous thromboembolism and subsequent receipt of disability pension - a population-based prospective cohort study. Journal of Thrombosis and Haemostasis. 11. 442–443. 2 indexed citations
18.
Johannesdottir, Sigrun Alba, Erzsébet Horváth–Puhó, Olaf M. Dekkers, et al.. (2013). Use of Glucocorticoids and Risk of Venous Thromboembolism. JAMA Internal Medicine. 173(9). 743–743. 325 indexed citations
19.
Cessie, Saskia le, J. Debeij, Frits R. Rosendaal, Suzanne C. Cannegieter, & Jan P. Vandenbroucke. (2012). Quantification of Bias in Direct Effects Estimates Due to Different Types of Measurement Error in the Mediator. Epidemiology. 23(4). 551–560. 65 indexed citations
20.
Stuijver, Danka J. F., Bregje van Zaane, Richard A. Feelders, et al.. (2011). Incidence of Venous Thromboembolism in Patients with Cushing's Syndrome: A Multicenter Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 96(11). 3525–3532. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Verhamme Breakdown of academic impact, for papers by James D. Douketis Breakdown of academic impact, for papers by Saskia Middeldorp Breakdown of academic impact, for papers by Kenneth A. Bauer Breakdown of academic impact, for papers by Walter Ageno Breakdown of academic impact, for papers by Peter K. Henke Breakdown of academic impact, for papers by Francesco Dentali Breakdown of academic impact, for papers by Marc Rodger Breakdown of academic impact, for papers by Stavros Konstantinides Breakdown of academic impact, for papers by Philip S. Wells
Rankless by CCL
2026